• Products
  • Community
  • Markets
  • Brokers
  • More
Get started
  • Markets
  • /Denmark
  • /Stocks
  • /Ideas
Ørsted expected to be bullish from hereIt seems that Ørsted has completed the correction and now will start a bullish move during from here. There is missing volume at 500 and it is expected that this area will be reached during 2025. Earnings coming up soon.
OMXCOP:ORSTEDLong
by jespergarm
MAERSK - End of roadIn the short term, very high selling pressure. In the long term, it looks like there is a plenty of space upward.
OMXCOP:MAERSK_BLong
by EmreSrn
NOVO has developed an H&S formationAs others have also mentioned on Trading View, NOVO has developed an H&S formation. The formation is to some extent supported by volume. Volume should be large when forming the left shoulder 1, as well as when forming the head 2, and when the price goes down at the right shoulder 4, but when forming the right shoulder the volume should be low 3. It is not. Since May, the volume balance has been negative, i.e. high volume at the price bottom and low volume at the price peak. At 794, there
OMXCOP:NOVO_B
by scorpiris
Updated
1
NOVO - Short term targetSupport Resistance Weekly support works Wave We expect a potential correction aligning with Fibonacci levels RSI - No reversal signal yet Daily - Oversold Weekly - Oversold MACD - No reversal signal yet Daily - Sell histograms is growing Weekly - Sell histograms is growing Opening price 625 Take profit 1 660 Take Profit 2 692 Stop loss 584
OMXCOP:NOVO_BLong
by EmreSrn
Novo Nordisk hit my target this week and I have started to buy The head and shoulders pattern successfully played out, with OMXCOP:NOVO_B reaching my full target at 670. Check out my original post: The stock experienced a significant drop, falling as much as 27% on the Friday before Christmas. This was triggered by test results for their obesity drug, CagriSema, which showed patient weight loss of 22.7% - below the anticipated 25%. I believe this reaction is an overcorrection and have taken advantage of this rare opportunity to purchase OMXCOP:NOVO_B
OMXCOP:NOVO_BLong
by madsroland
1
Novo completely oversold🐂 Trade Idea: Long - NOVO 🔥 Account Risk: 20.00% 📈 Recommended Product: Stock 🔍 Entry: +/- 750.00 🐿 DCA: No 😫 Stop-Loss: 675.00 🎯 Take-Profit #1: 1,000.00 (50%) 🎯 Trail Rest: Yes 🚨🚨🚨 Important: Don’t forget to always wait for strong confirmation once possible entry zone is reached. Trade ideas don’t work all the time no matter how good they look. Do not get a victim of FOMO, there is always another trade idea waiting. 🚨🚨🚨 If you like what you see don’t forget to leave a comment 💬 or sma
OMXCOP:NOVO_BLong
by LGNDRY-Capital
Updated
2
Orsted daily bottomLook for signs of reversal between 300-325. AB=CD to possible channel bottom/doubling of earlier channel and zone.
OMXCOP:ORSTEDLong
by BaliShag
Multi year breakoutLeading financial bank with multi year breakout. You can clearly see VCP pattern.
OMXCOP:SJFLong
by yash_gurjar_07
BAVA: finally a breakoutAccording to analysts the average Target is 319 whereas the max Target us 373. Happy trading Folks
OMXCOP:BAVALong
by darth.stocks
MAERSK UptrendTREND According to the wave structure, it is still in the downtrend However, head and shoulders formation is a powerful reversal indicator. It also formed a blue channel , now targeting the upper band Moving Averages 20-day (Red) crosses 50-day (Orange) from down to up (powerful indicator supporting uptrend) 100-day (Turquoise) is below the current price (so supports uptrend) 200-day (Blue) is right below the current price (it becomes support now) SUMMARY Based on this analys
OMXCOP:MAERSK_BLong
by EmreSrn
NOVO Up TrendTREND We may be at the end of the correction, namely the 3 ABC waves within the downward (orange) channel. It may form a reversal formation with the blue harmonic pattern. At the same time, the TOBO formation will also be formed. MA In this case, the 100-day (turquoise) will have worked as support. The last 100-day was seen in 2021. Thus, the upward trend can continue without breaking the 20-day to 50-day.
OMXCOP:NOVO_BLong
by EmreSrn
NOVO Down TrendTREND The red trend line from 2022 has been broken. It may be doing a pullback for confirmation. It continues its movement within the orange channel that started in 2024. It may be the 3rd of the 5-wave. The green trend line from 2021 is the first target before the purple main support. The purple support formed in 2023 is the strongest level. It is also Fibo 0.618. MA 20-day (Red), 50-day (Orange) is cutting down from the top. 100-day (Turquoise) has been working as support since
OMXCOP:NOVO_BShort
by EmreSrn
1
Carlsberg 2h first PB?IHS at weekly channel low. AB=CD/possible first pullback to zones and channel low. Take it at least to gap close.
OMXCOP:CARL_BLong
by BaliShag
New Zealand dollar eyes RBNZ rate announcementThe New Zealand dollar is in positive territory on Tuesday, after a four-day losing streak. In the European session, NZD/USD is trading at 0.5850, up 0.09% on the day. Earlier, the New Zealand dollar fell as low as 0.5797, its lowest level since Nov. 1. The Reserve Bank of New Zealand makes its rate announcement on Wednesday and the markets have priced in a jumbo rate cut of a 50 basis point for a second straight meeting. This would bring the cash rate to 4.25%, its lowest level since November
OMXCOP:FED
by OANDA
BAVA: bullish 3 drives18 % Upside potential with little risk since earnings are coming out on friday
OMXCOP:BAVALong
by darth.stocks
Updated
Revising the head and shoulders pattern on NOVOSince my previous analysis on Novo Nordisk OMXCOP:NOVO_B , the price has nearly reached the original target of 700. However, I have made slight adjustments to the head and shoulders pattern, which has consequently led to a revised target at the value area low of the range from late 2023 at around 670. At this point, I would not consider this an ideal time to initiate a short position on OMXCOP:NOVO_B . Instead, it appears to be more of a profit-taking opportunity for those who entered
OMXCOP:NOVO_BShort
by madsroland
You can buy it here.. Its fineOMXCOP:VWS Recent pullback is a fine buying opportunity. Maybe we bottomed and break the downtrend now, Maybe we have a leg lower to ~120 - a chance to back up the truck. In any case this one will AT LEAST double in value over the next 3 years. Europe will make a lot of windmills in the next 3 years, it is vital for the future of European energy independence, so if you believe there is a future - then this is a good company to build a position in this winter. Cheers.
OMXCOP:VWSLong
by PotatoJuice99
Updated
4
NOVO NORDISKBearish trend with a Shoulder-Head-Shoulder pattern with price target around 630DK. However, could fall a bit more if it tests support around 620DK.
OMXCOP:NOVO_BShort
by oriol987
Novo Nordisk Correction: Key Levels & Opportunities for InvestorNovo Nordisk, Europe’s largest publicly traded company, has experienced exceptional growth, especially in the diabetes and obesity treatment markets. Known globally for its expertise in insulin production, Novo Nordisk has also recently expanded into the obesity treatment market with products like Wegovy, which have seen rapid adoption and driven substantial revenue gains. Strong financials and a robust R&D pipeline make it a leading global player, well-positioned for future growth in metabolic
OMXCOP:NOVO_BLong
by VaidoVeek
DFDS weekly/monthly repeatI've been looking at the scenario for over a year, but it just seemed too extreme... Not anymore though. Let's see. Should at least move up to the quarterline if successful, which is about 60%!
OMXCOP:DFDSLong
by BaliShag
NOVO NORDISK: recovering from sicknessThe current market setup for Novo shows a clear consolidation within the larger trend structure, indicating key decision points ahead for traders. If the resistence breaks and stays over it the stock should have a good time. It could be that the price falls to DKK750-710 but should recover from this point on. Thank you for taking the time to read my analysis. I look forward to hearing your thoughts. Best regards, Mattner. no investment advice
OMXCOP:NOVO_BLong
by thefuturefrontier
Novo Nordisk could be dropping 15% from hereLooking at Novo Nordisk and the fundamental I have a hard time thinking Novo would drop further at this point. However the technical setup indicates that if we don't hold the current level we could drop more than 15% from here. - The head and shoulder is complete now we just need to see if we can get a follow through. - Closing price Friday was below the 200 daily moving average. The recent price drop is caused by a dissapoint in early trial results of their pill Monlunabant.
OMXCOP:NOVO_BShort
by madsroland
Ørsted broke multi-year downward trendlineSince 2021, Ørsted has been in a bearish trend overall. A trendline drawn from then to now shows that the stock price has just climbed over it. Looking at the support levels, the price has just claimed the last one at around 420. Next level sits at 548.
OMXCOP:ORSTEDLong
by simonkolina
1
MAERSK Inverse Head and ShouldersMaersk is potentially bottoming and forming an inverse head and shoulders. Price has also retraced to the 0.618 retracement of the move up from end of March. PT: 13380, 16180
OMXCOP:MAERSK_ALong
by andrewyu02
12345678910111213141516171819202122
…999

Made by humans

Select market data provided by ICE Data Services. Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.Copyright © 2026, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC filings and other documents provided by Quartr.© 2026 TradingView, Inc.

SOC 2 CompliantGDPR Compliant
More than a product
  • Supercharts
Screeners
  • Stocks
  • ETFs
  • Bonds
  • Crypto coins
  • CEX pairs
  • DEX pairs
  • Pine
Heatmaps
  • Stocks
  • ETFs
  • Crypto coins
Calendars
  • Economic
  • Earnings
  • Dividends
  • IPOs
More products
  • News Flow
  • Portfolios
  • Fundamental Graphs
  • Yield Curves
  • Options
  • Macro Maps
  • Pine Script®
  • MCP Server
Apps
  • Mobile
  • Desktop
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • Creator program
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
  • Marketplace
Tools & subscriptions
  • Features
  • Pricing
  • Market data
  • Gift plans
Trading
  • Overview
  • Brokers
  • Brokers comparison
  • The Leap
Special offers
  • CME Group futures
  • Eurex futures
  • US stocks bundle
About company
  • Who we are
  • Space mission
  • Blog
  • Help Center
  • Careers
  • Media kit
Merch
  • TradingView store
  • Tarot cards for traders
  • The C63 TradeTime
Policies & security
  • Terms of Use
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Accessibility Statement
  • Trust Center
  • Security tips
  • Bug Bounty program
  • Status page
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • Creator program
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
  • Marketplace
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Look FirstLook First